Your browser doesn't support javascript.
Corrigendum to "Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study" [Vaccine: X 11 (2022) 100189].
Sáez-Llorens, Xavier; Lanata, Claudio; Aranguren, Elaine; Celis, Carlos R; Cornejo, Rubelio; DeAntonio, Rodrigo; Ecker, Lucie; Garrido, Diegi; Gil, Ana I; Gonzales, Marina; Hess-Holtz, Morgan; Leroux-Roels, Geert; Junker, Helga; Kays, Sarah-Katharina; Koch, Sven D; Lazzaro, Sandra; Mann, Philipp; Quintini, Gianluca; Srivastava, Barkha; Vahrenhorst, Dominik; von Eisenhart-Rothe, Philipp; Wolz, Olaf-Oliver; Oostvogels, Lidia.
  • Sáez-Llorens X; Cevaxin, The Panama Clinic, Panama City, Panama.
  • Lanata C; Instituto de Investigación Nutricional, Lima, Peru.
  • Aranguren E; Cevaxin, The Panama Clinic, Panama City, Panama.
  • Celis CR; Instituto de Investigación Nutricional, La Molina, Peru.
  • Cornejo R; Instituto de Investigación Nutricional, Lima, Peru.
  • DeAntonio R; Cevaxin, The Panama Clinic, Panama City, Panama.
  • Ecker L; Instituto de Investigación Nutricional, Lima, Peru.
  • Garrido D; Cevaxin, The Panama Clinic, Panama City, Panama.
  • Gil AI; Instituto de Investigación Nutricional, La Molina, Peru.
  • Gonzales M; CureVac AG, Tübingen, Germany.
  • Hess-Holtz M; Cevaxin, The Panama Clinic, Panama City, Panama.
  • Leroux-Roels G; Ghent University Hospital, Ghent, Belgium.
  • Junker H; CureVac AG, Frankfurt, Germany.
  • Kays SK; Ghent University Hospital, Ghent, Belgium.
  • Koch SD; CureVac AG, Tübingen, Germany.
  • Lazzaro S; CureVac AG, Tübingen, Germany.
  • Mann P; CureVac AG, Frankfurt, Germany.
  • Quintini G; CureVac AG, Tübingen, Germany.
  • Srivastava B; CureVac AG, Tübingen, Germany.
  • Vahrenhorst D; CureVac AG, Tübingen, Germany.
  • von Eisenhart-Rothe P; CureVac AG, Tübingen, Germany.
  • Wolz OO; CureVac AG, Tübingen, Germany.
  • Oostvogels L; CureVac AG, Frankfurt, Germany.
Vaccine X ; 14: 100307, 2023 Aug.
Article in English | MEDLINE | ID: covidwho-20231272
ABSTRACT
[This corrects the article DOI 10.1016/j.jvacx.2022.100189.].
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Language: English Journal: Vaccine X Year: 2023 Document Type: Article Affiliation country: J.jvacx.2023.100307

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Language: English Journal: Vaccine X Year: 2023 Document Type: Article Affiliation country: J.jvacx.2023.100307